Core Viewpoint - HLD Europe has entered into an agreement to sell 9.8% of Exosens' share capital to Theon International at a price of €54 per share, highlighting Exosens' strategic positioning and growth potential in the night vision market [2][3]. Group 1: Transaction Details - The sale price of €54 per share reflects the recognition of Exosens' unique strategic positioning and strong growth potential identified by its largest night vision customer [2]. - The transaction is expected to complete in early Q1 2026, pending regulatory notifications [3]. - After the transaction, HLD Europe will remain the largest shareholder of Exosens, holding 22.42% of the company's capital [3]. Group 2: Company Overview - Exosens is a high-tech company with over 85 years of experience in developing and manufacturing high-end electro-optical technologies [5]. - The company offers a range of detection components and solutions, including travelling wave tubes, advanced cameras, and neutron & gamma detectors, catering to complex issues in demanding environments [5]. - Exosens is recognized as a major innovator in optoelectronics, with production and R&D across 12 sites in Europe and North America, employing over 1,800 people [5].